Neoadjuvant drug-eluting bead transarterial chemoembolization and tislelizumab therapy for resectable or borderline resectable hepatocellular carcinoma: A propensity score matching analysis-Reference-Cited by-同舟云学术

Neoadjuvant drug-eluting bead transarterial chemoembolization and tislelizumab therapy for resectable or borderline resectable hepatocellular carcinoma: A propensity score matching analysis

Published:2023-12 Issue:12 Volume:49 Page:107106
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Zhao Jianping,Wang Jingjing,Lu Yuanxiang,Wu Yang,Kuang Dong,Wang Ying,Luo Hongchang,Xu Anhui,Zhang Wanguang

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference38 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J Clin,2021

2. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries;Zeng;Lancet Global Health,2018

3. A prospective study using propensity score matching to compare long-term survival outcomes after robotic-assisted, laparoscopic or open liver resection for patients with BCLC stage 0-A hepatocellular carcinoma;Zhu;Ann Surg,2022

4. Microvascular invasion in hepatocellular carcinoma: a review of its definition, clinical significance, and comprehensive management;Zheng;Journal of oncology,2022

5. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation;Lee;Ann Surg,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant-Based Triple Therapy for Hepatocellular Carcinoma with Type I/II Portal Vein Tumor Thrombosis;Journal of Hepatocellular Carcinoma;2024-08

2. Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced hepatocellular carcinoma;2024-06-11

3. Recent advances in surgical management strategies for hepatocellular carcinoma;hLife;2024-06

4. Letter to Editor: ‘Identification of patients with favorable prognosis after resection in intermediate-stage hepatocellular carcinoma’;International Journal of Surgery;2024-05-20

5. Letter to the editor: Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study;International Journal of Surgery;2024-03-25